Corebridge Financial, Inc.

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-14
Total Holdings
3,016
Total Value
17392076023
Accession Number
0001889539-25-000038
Form Type
13F-HR
Manager Name
Corebridge Financial, Inc.
Data Enrichment
98% identified
2,948 identified68 unidentified

Holdings

3,016 positions
Manager:
Search and click to pin securities to the top
Page 139 of 151
Coherus BioSciences, Inc.
Shares:
55061(-0.5%)
Value:
$44.4M(-41.8%)
Wheels Up Experience Inc.
Shares:
43939(-1.4%)
Value:
$44.4M(-39.7%)
Larimar Therapeutics, Inc.
Shares:
20609(-1.5%)
Value:
$44.3M(-45.3%)
Vestis Corp
Shares:
4468(-9.7%)
Value:
$44.2M(-41.3%)
biote Corp.
Shares:
13189(-1.4%)
Value:
$43.9M(-46.9%)
SentinelOne, Inc.
Shares:
2406(-2.0%)
Value:
$43.7M(-19.7%)
Blink Charging Co.
Shares:
47132(-1.5%)
Value:
$43.3M(-34.9%)
Solid Biosciences Inc.
Shares:
11643(+2.6%)
Value:
$43.1M(-5.1%)
GEOSPACE TECHNOLOGIES CORP
Shares:
5965(-1.5%)
Value:
$43.0M(-29.1%)
Certara, Inc.
Shares:
4343(-7.5%)
Value:
$43.0M(-14.0%)
Quipt Home Medical Corp.
Shares:
18327(-10.9%)
Value:
$42.7M(-31.9%)
Lyell Immunopharma, Inc.
Shares:
78727(-1.5%)
Value:
$42.4M(-17.2%)
Schneider National, Inc.
Shares:
1829(-7.6%)
Value:
$41.8M(-27.9%)
Sight Sciences, Inc.
Shares:
17405(-1.5%)
Value:
$41.8M(-35.0%)
Neumora Therapeutics, Inc.
Shares:
41753(-0.1%)
Value:
$41.8M(-90.6%)
ATOSSA THERAPEUTICS, INC.
Shares:
61966(-1.4%)
Value:
$41.7M(-29.8%)
Apellis Pharmaceuticals, Inc.
Shares:
1901(-1.2%)
Value:
$41.6M(-32.3%)
EGAIN Corp
Shares:
8569(-1.5%)
Value:
$41.6M(-23.3%)
GoPro, Inc.
Shares:
62513(+0.5%)
Value:
$41.4M(-38.9%)
Loar Holdings Inc.
Shares:
586(+11.8%)
Value:
$41.4M(+6.9%)